. My original plan was to go back to France, but life happened, and after ten years at Yale University, I recently relocated to the University of Virginia, where I am very excited to start my own laboratory. When I look back at the past 15 years of my scientific career, I see some ups and downs. To be honest, there were probably more downs, and without a genuine passion for what I do and the strong support and guidance from various mentors and colleagues, I would probably not be writing this piece. But most importantly, the ups have carried me through the storms of grants and paper submissions. They are so gratifying and uplifting that no matter how many downs will come my way, I know I have chosen the right career path.
I decided to study Chlamydia because I found its developmental cycle fascinating and I wanted to understand the molecular mechanisms behind it. Why? Partly for the sake of knowledge. Unfortunately, in today's society, investing in knowledge may not be perceived as one of the highest priorities. In my opinion, however, it is critical to continue our scientific investigations aiming to understand the world around us and "within" us, in the case of intracellular bacteria. Our curiosity-driven research allows for the exploration of new and different ideas, and by following up on discoveries, wherever they lead, basic research scientists contribute to the realization of a never-ending puzzle. Results gathered from basic research will contribute to tomorrow's textbooks, will advance the knowledge of the next generations, and will hopefully incite them to pursue our endeavor. In addition to contributing to knowledge, I also chose to study Chlamydia because of its relevance to human health. Through basic research, the identification of bacterial and host factors supporting pathogen infection constitutes a major avenue for designing novel approaches to therapeutically interfere with the infection process. Therefore, novel therapeutic interventions explored through translational research critically rely on basic research.
Only time will tell whether my research program will significantly contribute to the genesis of knowledge as well as novel therapeutic interventions. We have performed genetic screens to identify host factors that are required for Chlamydia intracellular replication. These studies led to the identification of a novel mechanism by which Chlamydia potentially hijack host cellular lipids that are important for the completion of its developmental cycle. Furthermore, we have identified a Chlamydia type III secretion effector protein that mediates the hijacking process. As we further characterize and understand this pathway, we envision novel approaches for interfering with Chlamydia development and therefore blocking the infection process. In addition, because the use of secretion systems is a common theme among some intracellular bacteria, our research program has the potential to shed light onto conserved mechanisms used by other bacterial pathogens. Finally, everything we learn about Chlamydia interaction with the host may also help understand basic cellular processes, which in turn may be beneficial to our understanding of noninfectious human diseases. So, although there may not be any immediate applications, we shall not forget that over time, collective knowledge gathered through basic research is the foundation of any kind of translational research and that at the end of day, every little piece of the puzzle matters.
